Streetbeat News

Stock Prices

ABT

Barclays analyst Matt Miksic has maintained an Overweight rating on Abbott Laboratories (NYSE:ABT) and increased the price target from $133 to $141, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:22 pm

AXP

DIA

INTC

QQQ

SMH

SPY

XLK

XLV

Stocks showed mixed performance despite mild inflation data, with the S&P 500 and Nasdaq 100 slightly down, while the Dow Jones edged higher. Personal spending growth outpaced expectations, raising concerns about the Fed's interest rate policy. Bitcoin rallied after hitting 1 million active addresses. Tech stocks and semiconductors fell, with Intel's weak forecast impacting the sector. American Express surged on a strong outlook, while other companies had varied reactions to earnings reports.

Portfolio Pulse from Piero Cingari

January 26, 2024 | 6:18 pm

BTSG

BrightSpring Health Services Inc. has launched its initial public offering (IPO) with shares opening at $12.00. The company, which may be referred to by its ticker symbol BTSG, is now publicly traded and investors can purchase shares at the opening price.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:17 pm

General Motors (NYSE:GM) has seen a decrease in short interest, with the short percent of float falling 4.14% since the last report. The company has 110.71 million shares sold short, which is 8.11% of available shares for trading. The current short interest is lower than the peer group average of 10.24%. While a decline in short interest can indicate a more bullish sentiment, it does not necessarily predict a near-term rise in stock price.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 6:15 pm

ILMN

Illumina's (NYSE:ILMN) short interest has increased by 8.97% since the last report, with 4.65 million shares sold short, representing 3.28% of available shares. It would take 2.1 days to cover these short positions based on current trading volume. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop. Illumina has less short interest compared to its peer group average of 5.65%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 6:15 pm

PHUN

Phunware Inc. (NYSE:PHUN) has seen a significant decrease in short interest, with a 50.97% drop since the last report. The current short interest stands at 11.86 million shares, or 3.54% of the float, with a short-covering time of 2.45 days. This decline in short interest may indicate a more bullish sentiment among investors compared to the peer group average short interest of 4.37%.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 6:15 pm

TSLA

Wedbush analyst Daniel Ives lowered Tesla's price target from $350 to $315 and removed it from the Best Ideas List after a disappointing Q4 report and vague 2024 guidance. Ives criticized Tesla's earnings call and suggested a 10-point plan to improve share performance, including a $10 billion buyback, a new 'X Holding' structure for AI initiatives, maintaining automotive margins, hosting an AI Day, securing outside capital for X/Twitter, a new CEO compensation package, setting a Model 2 production timeline, returning to formal guidance, AI acquisitions, and setting long-term AI targets.

Portfolio Pulse from Chris Katje

January 26, 2024 | 6:15 pm

HUM

Stephens & Co. analyst Scott Fidel has maintained an Overweight rating on Humana (NYSE:HUM) but reduced the price target from $550 to $430.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:09 pm

GNTX

Gentex Corp (NASDAQ:GNTX) shares rose after reporting Q4 financial results surpassing expectations. Sales increased 19% Y/Y to $589.1 million, exceeding analyst estimates of $560.8 million. EPS was $0.50, beating the $0.44 consensus. Automotive net sales climbed to $578.7 million, with auto-dimming mirror shipments up 12%. Gross profit margin improved to 34.5% from 31.2% due to price increases and cost recoveries. Operating income jumped 41% Y/Y to $132.8 million. The company repurchased 2.2 million shares and ended the quarter with $240.8 million in cash. FY24 revenue is projected between $2.45 billion and $2.55 billion, aligning with consensus estimates, and FY25 revenue is forecasted at $2.65 billion to $2.75 billion. CEO Steve Downing outlined plans for further gross margin improvements. GNTX shares surged 7.202% to $34.13.

Portfolio Pulse from Lekha Gupta

January 26, 2024 | 6:07 pm

HTGC

JEPI

TOST

On CNBC's Halftime Report, analysts shared their final trades, which included Toast Inc. (TOST), JPMorgan Equity Premium Income ETF (JEPI), Hercules Capital (HTGC), and General Motors (GM). These recommendations provide insights into the analysts' views on these assets.

Portfolio Pulse from Benzinga Newsdesk

January 26, 2024 | 6:07 pm